Data protection Impressum

Biotech

The FIT has awarded three Tech Seed loans of CHF 100,000 each to early-stage start-ups CCRAFT, Databaum and Lemna Bio.

FIT backs three start-ups to advance photonics, agritech and AI-driven drug discovery

23 December 2025

The canton of Fribourg is building a distinctive growth model at the crossroads of industry, luxury and innovation, combining precision manufacturing, advanced technologies and long-term value creation.

Fribourg: where discreet excellence powers high-value industries

17 December 2025

DigeHealth has raised CHF 1.25 million to accelerate the development of a wearable device that continuously monitors gastrointestinal activity using acoustics and artificial intelligence.

DigeHealth raises CHF 1.25 million to advance continuous gastrointestinal monitoring

15 December 2025

Researchers at CHUV have validated a new stem-cell–based method to study autoimmune diseases in organs such as the brain, offering new insights into conditions like autoimmune encephalitis and multiple sclerosis.

CHUV researchers develop new method to study autoimmune diseases

2 December 2025

Takeda has opened a new CHF 200 million biotechnology facility in Neuchâtel to expand aseptic filling capacity for rare disease therapies.

Takeda inaugurates CHF 200 million biotechnology facility in Neuchâtel

1 December 2025

A Swiss-led research consortium is developing an AI-powered microfactory capable of producing patient-specific tumor models to revolutionize precision oncology.

ORION: A smart microfactory to accelerate personalized cancer treatments

10 November 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (October 2025)

29 October 2025

The Munich- and Lausanne-based biotech secures Europe’s largest-ever Series C financing to accelerate development of next-generation antibody-drug conjugates.

Tubulis raises EUR 308 million to advance ADC therapies and expand its clinical pipeline

29 October 2025

Adaptyv raises USD 8 million to accelerate AI-powered protein validation

27 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

1 2 3 4 5 6 7 8 … 19